$ILMN

Meister Keith A. sold $850K of ILMN (indirect holdings)

Meister Keith A. sold 5,256 indirectly-held shares of ILLUMINA, INC. (ILMN) at $161.64 ($0.85M total) on 2026-05-29.

Original reporting
SEC EDGAR · Meister Keith A.
Published Jun 1, 2026, 10:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ILMN
Neutral
medium confidence
Mentioned
$ILMN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ILMNNeutralLow
01

Why it matters

The disclosure provides a new datapoint on insider behavior, but it does not introduce new operational or financial information about Illumina.

02

Market read

Traders may briefly reassess sentiment around ILMN, but the event is unlikely to drive a durable repricing without additional fundamental catalysts.

03

What to watch

No 10b5-1 plan is cited, which can raise scrutiny; traders may watch for follow-on insider buys/sales or other filings around the same period.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed today; sale executed 2026-05-29

Background

The article is an SEC Form 4 insider transaction disclosure for Illumina (ILMN).

Company-level read

Ticker impact

$ILMNNeutralMedium confidence
Context

Illumina director Keith A. Meister sold $849.6K of ILMN shares in an open-market transaction disclosed via SEC Form 4.

Expected impact

Low likelihood of a sustained price move; any impact is likely short-lived unless accompanied by additional disclosures.

Evidence & confidence

The filing is an ownership-change disclosure with no stated earnings/guidance, deal, or regulatory development; also notes no 10b5-1 plan, which can increase attention but still lacks new business information.

Market effects

Minimal—this is company-specific insider activity rather than a sector-wide signal.

Minimal—no geographic or macro linkage indicated.

Minimal—no global deal/regulatory development tied to the transaction.

Counterpoint

Because the sale is disclosed after execution and lacks a stated reason, it may reflect diversification/liquidity rather than negative outlook.

Key entities

  • Illumina, Inc.

    Subject of the SEC Form 4 insider sale by a director.

  • Meister Keith A.

    Director who sold 5,256 shares at $161.64/share (total ~$849.6K).

Related articles

$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Illumina (ILMN) reported Q2 2026 revenue of $1.16B, up 9.5% YoY, and non-GAAP EPS of $1.31. Clinical consumables and NovaSeq X placements drove results. Gross margin was 68.2%. Full-year 2026 guidance was raised to $4.60B-$4.64B revenue and $5.30-$5.40 EPS. Cash was $1.17B vs $1.99B debt.

$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Conor McNamara Chief Executive Officer - Jacob Thaysen Chief Financial Officer - Ankur Dhingra TAKEAWAYS Total Revenue -- $1.16 billion, representing a 9.5% increase year over year driven by clinical market demand and the NovaSeq X expansion. Rest of World Organic Revenue -- Increased 8.1% year over year, exceeding the high end of management's previous guidance.

$ILMNMedAI 8/10

Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full

Genomics company Illumina (NASDAQ: ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.62 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.31 per share was 6.8% above analysts’ consensus estimates. Is now the time to buy Illumina? Find out by accessing our full research report, it’s free.

$ILMNHigh

ILLUMINA, INC. (ILMN): Results of Operations and Financial Condition

ILLUMINA, INC. (ILMN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q226earningsrelease.htm EX-99.1 Document Investors: Conor McNamara +1.858.291.6421 ir@illumina.com Media: Christine Douglass pr@illumina.com Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026 San Diego, July 30, 2026 /PRNewswire/ -- Illumina, Inc.